Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • PratikC
    Member
    • Sep 2011
    • 16

    #16
    Guys, what do you say about cloud computing? If anyone has experience of clouds, please suggest which one is better in terms of cost and processing? We have got 10 Mbps dedicated line and we are going to do human exome sequencing not whole genome.

    If anyone knows good resources for tutorial/guide line to run NGS analysis on cluster and or cloud, please tell me because doing this IT related stuff only on my own is little bit difficult for me.
    Thanks in advance.

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #17
      If you are going to use a cloud provider like amazon then remember that you are going to pay for getting data in to the cloud (and then getting the results out). If you are planning to store that data then figure that cost in as well. If your ISP charges you for the data based on traffic volume going over that dedicated line then the costs will add up rapidly.

      A 50 bp single end HiSeq Illumina sequence data file can be 20-30 GB (even if you multiplex, the file size per lane will add up to this). Depending on how many samples you are planning to run do the calculation of what you will pay to move (along with the time it till take to move the data) and store that data before considering cloud computing.

      There is a nice write-up about running a tool called "Galaxy" in the cloud here: http://wiki.g2.bx.psu.edu/Admin/Cloud. Galaxy has a nice suite of NGS tools built in.

      Originally posted by PratikC View Post
      Guys, what do you say about cloud computing? If anyone has experience of clouds, please suggest which one is better in terms of cost and processing? We have got 10 Mbps dedicated line and we are going to do human exome sequencing not whole genome.

      If anyone knows good resources for tutorial/guide line to run NGS analysis on cluster and or cloud, please tell me because doing this IT related stuff only on my own is little bit difficult for me.
      Thanks in advance.

      Comment

      • PratikC
        Member
        • Sep 2011
        • 16

        #18
        Thank you very much GenoMax, the link you gave is very useful.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        15 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        32 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Working...